GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Current Deferred Revenue

Optimind Pharma (XCNQ:OMND) Current Deferred Revenue : C$0.00 Mil (As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Optimind Pharma's current deferred revenue for the quarter that ended in Nov. 2023 was C$0.00 Mil.

Optimind Pharma Current Deferred Revenue Historical Data

The historical data trend for Optimind Pharma's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Current Deferred Revenue Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
Current Deferred Revenue
- -

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Current Deferred Revenue Get a 7-Day Free Trial - - - - -

Optimind Pharma Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Current Deferred Revenue
Comparable Companies
XCNQ:NLV TSXV:GENX XCNQ:AYUR XCNQ:PHRX XCNQ:J XCNQ:CRCC XCNQ:BCBC XCNQ:CVGR XCNQ:PBF TSXV:HMPG ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Website
https://www.optimindpharma.com
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines